· Form D filing · Baseline
Reported sold as filed: $7,833,333 · Offering amount as filed: $30,000,000
SEC source checked 4 Nov 2026. This is the issuer’s historical filing, not a current valuation.
View original evidence ↗Lungpacer Medical, Inc.
On its website, the company describes its work as “The AeroPace temporary transvenous diaphragm neurostimulation system stimulates the phrenic nerves that control the diaphragm using an intuitive catheter-based approach that fits seamlessly into existing…”.
- Industry
- Other Health Care
- Tracked VC backers
- 0
Tracking coverage and points
Tracking coverage
Some source history is available; coverage remains limited.
- Momentum +1 · Limited coverage
- The latest public index does not report a rank for this company.Index checked:
- Fundraising +2 · Limited coverage
- Verified filings recorded. Existing baseline history earns no points.SEC source checked:
- New VC +3 · Awaiting data
- No verified dated source evidence recorded.
- Completed exit +10 · Awaiting data
- Exit news coverage has not started.
Coverage describes public evidence. Points require a qualifying milestone after your pick.
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
No tracked VC backing is recorded.